AGTR1 and atherosclerosis: Moreover, depending on the dose of sacubitril and its effects on circulating AngII concentrations, our results do not support NEP inhibition in the absence of sufficient AT1R blockade as an effective therapeutic approach for AngII-induced atherosclerosis.